Announcements Trials
Browse Landscape

Phase

Phase 2 254Phase 1 64Phase 1/2 47Phase 3 23Phase NA 9Phase EARLY_PHASE1 5Phase 4 5Phase 2/3 5

Status

Not yet recruiting 2Unknown 1Recruiting 1Completed 1

Sponsor Class

INDUSTRY 9OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 2Breast 2Thoracic 1

Conditions

Triple Negative Breast Neoplasms 1Thymoma 1Thymic epithelial tumor 1Mediastinal Neoplasms 1Gallbladder Neoplasms 1Esophageal Squamous Cell Carcinoma 1Breast Neoplasms 1Biliary Tract Neoplasms 1

Interventions

Cisplatin 54Cyclophosphamide 42Fluorouracil 41Oxaliplatin 36Capecitabine 35Docetaxel 34Gemcitabine 32Drug Therapy 32Radiotherapy 31Paclitaxel 25Dexamethasone 23Carboplatin 23Leucovorin 21Etoposide 17Doxorubicin 17Cytarabine 17apatinib 16Methotrexate 16Magnetic Resonance Spectroscopy 14Radiation 13Epirubicin 13Busulfan 13Bevacizumab 13Surgical Procedures, Operative 12Neoadjuvant Therapy 12Letrozole 12Decitabine 12Saline Solution 11Irinotecan 11venetoclax 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2/3 × OTHER × 130-nm albumin-bound paclitaxel × Clear all
NCT07463313 2026-03-11

6 vs 3 Cycles of Neoadjuvant Chemotherapy for Potentially Resectable Locally Advanced Thymic Epithelial Tumors

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Phase 2/3 Not yet recruiting
116 enrolled
Thoracic

Thymic epithelial tumor, Mediastinal Neoplasms, Thymoma

NCT06214572 2025-04-11

RUGB

Tata Memorial Centre

Phase 2/3 Recruiting
249 enrolled
Gastrointestinal

Biliary Tract Neoplasms, Gallbladder Neoplasms

NCT06861777 2025-03-11

Total Neoadjuvant Therapy Combined With Adebrelimab in Locally Advanced Resectable ESCC

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2/3 Not yet recruiting
474 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT04907344 2021-05-28

Study of Camrelizumab Plus Chemotherapy as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC)

Tianjin Medical University Cancer Institute and Hospital

Phase 2/3 Unknown
420 enrolled
Breast

Triple Negative Breast Neoplasms

NCT01204437 2016-02-10

ICE-II

GBG Forschungs GmbH

Phase 2/3 Completed
400 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡